April 7, 2025 03:58 PM EDT

Minnesota federal judge dismisses challenge from AbbVie, AstraZeneca to state's 340B law

Max Bayer

Pharma Reporter

A federal judge in Minnesota knocked down challenges from two drugmakers against a state law that the companies argued overly expanded the scope of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Minnesota federal judge dismisses challenge from AbbVie, AstraZeneca to state's 340B law

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

‘This is self-inflicted’: Leerink’s David Risinger on the market shock and hits to biopharma

Stock market melts down over Trump’s tariffs, and biotech's pain keeps growing

RFK Jr. won’t testify before key Senate committee this week on HHS overhaul

Rare disease hub at CDER and CBER faces new reality with staff crunch

HHS says it may revisit anti-obesity drug policies after dropping Biden-era proposal

PureTech rejects cash exit proposal from Nordic Capital, investment firm says it won't make an offer

Min­neso­ta fed­er­al judge dis­miss­es chal­lenge from Ab­b­Vie, As­traZeneca to state's 340B law

Pharma Reporter

Sign up to read this article for free.

more like this

Celldex Therapeutics

Hampton, NJ, USA

Minnesota federal judge dismisses challenge from AbbVie, AstraZeneca to state's 340B law